Alpha 2.0
Login Register
» Articles » PMID: 35776002

Ulcerative Colitis Exacerbation After Rituximab Treatment in Posttransplant Lymphoproliferative Disease

Overview
Journal Radiol Imaging Cancer
Specialties Oncology
Radiology
Date 2022 Jul 1
PMID 35776002
Authors
Maximiliano Klug
Sara Apter
Yael Eshet
Edith Michelle Marom
Affiliations
Soon will be listed here.
Citing Articles

Machine learning-based B cell-related diagnostic biomarker signature and molecular subtypes characteristic of ulcerative colitis.

Wu G, Li L, Chen X, Zhang W, Wu J, Yu X Aging (Albany NY). 2024; 16(3):2774-2788.

PMID: 38319729 PMC: 10911385. DOI: 10.18632/aging.205510.

Impact of Anti-CD20 therapies on the immune homeostasis of gastrointestinal mucosa and their relationship with intestinal bowel disease in multiple sclerosis: a review.

Quesada-Simo A, Garrido-Marin A, Nos P, Gil-Perotin S Front Pharmacol. 2023; 14:1186016.

PMID: 37324473 PMC: 10263191. DOI: 10.3389/fphar.2023.1186016.

References
1.
Goetz M, Atreya R, Ghalibafian M, Galle P, Neurath M . Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis. 2007; 13(11):1365-8. DOI: 10.1002/ibd.20215. View
2.
Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E . High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2007; 35(1):95-9. DOI: 10.1007/s00259-007-0563-6. View
3.
El Fassi D, Nielsen C, Kjeldsen J, Clemmensen O, Hegedus L . Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves' disease. Gut. 2008; 57(5):714-5. DOI: 10.1136/gut.2007.138305. View
4.
Leiper K, Martin K, Ellis A, Subramanian S, Watson A, Christmas S . Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut. 2011; 60(11):1520-6. DOI: 10.1136/gut.2010.225482. View
5.
Trappe R, Oertel S, Leblond V, Mollee P, Sender M, Reinke P . Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2011; 13(2):196-206. DOI: 10.1016/S1470-2045(11)70300-X. View